Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Phase 2 study of intratumoral...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Phase 2 study of intratumoral vidutolimod in combination with intravenous cemiplimab in patients with selected advanced cancer or metastatic cancer: trial in progress

Phase 2 study of intratumoral vidutolimod in combination with intravenous cemiplimab in patients with selected advanced cancer or metastatic cancer: trial in progress

Bibliographic Details
Main Authors: S. Bhatia, D. Davar, S. Thomas, A.W. Silk, R.C. Wu, R. Ladwa, S.J. Park, C.M. Kelly, D.J. Wong, J. Grewal, N. Vohra, A.M. Lim, J. Puegero, C. Verschraegen, B. Zhong, I. Lowy, M. Fury, M. Cristea
Format: Article
Language:English
Published: Elsevier 2024-01-01
Series:EJC Skin Cancer
Online Access:http://www.sciencedirect.com/science/article/pii/S2772611824002283
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

http://www.sciencedirect.com/science/article/pii/S2772611824002283

Similar Items

  • Cemiplimab monotherapy in Japanese patients with recurrent or metastatic cervical cancer
    by: Kosei Hasegawa, et al.
    Published: (2024-09-01)
  • Monocytes Exposed to Immune Complexes Reduce pDC Type 1 Interferon Response to Vidutolimod
    by: Shakoora A. Sabree, et al.
    Published: (2021-09-01)
  • 1122 Vidutolimod, an immunostimulatory virus-like particle, reduces proliferation but enhances the activation of tumor-specific T cells
    by: George J Weiner, et al.
    Published: (2023-11-01)
  • Cemiplimab for Cisplatin Resistant Metastatic Penile Cancer
    by: Chloé Denis, et al.
    Published: (2021-06-01)
  • A Phase 1 study of fianlimab in combination with cemiplimab in patients with anti–PD-1/L1-experienced cutaneous squamous cell carcinoma
    by: J. Kaczmar, et al.
    Published: (2024-01-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs